Understanding market-specific terminology and authorized product information across Canada, the US, EU, UK, and Australia.
Authorized pharmaceutical product information terminology varies by jurisdiction: Product Monograph (PM) in Canada (Health Canada), Prescribing Information (PI or USPI) in the United States (US FDA), and Summary of Product Characteristics (SmPC or SPC) in the European Union (EMA) and UK (MHRA). These legal documents define approved indications, dosing, clinical pharmacology, contraindications, and safety warnings within their respective markets.
Product information refers broadly to the authorized information that describes a medicinal product and provides information relevant to its safe and appropriate use.
The exact terminology, format, content, and regulatory requirements can vary by jurisdiction, product type, and regulatory context. Because each health authority maintains its own legal frameworks and standards, there is no single universal document that applies identically worldwide.
Understanding market-specific terminology and authorized product information across Canada, the US, EU, UK, and Australia.